Evidence map›Paper›PMID 27020313›Full record

ArticleJournal of lipid research2016

Alcohol produces distinct hepatic lipidome and eicosanoid signature in lean and obese.

Puneet Puri, Jun Xu, Terhi Vihervaara, Riikka Katainen, Kim Ekroos, Kalyani Daita, Hae-Ki Min, Andrew Joyce, Faridoddin Mirshahi, Hidekazu Tsukamoto and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Xenobiotic-Induced Aggravation of Metabolic-Associated Fatty Liver Disease.International journal of molecular sciences · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Puneet PuriDivision of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA puneet.puri@vcuhealth.org.
Jun XuUniversity of Southern California, Los Angeles, CA.
Terhi VihervaaraZora Biosciences Oy, Espoo, Finland.
Riikka KatainenZora Biosciences Oy, Espoo, Finland.
Kim EkroosZora Biosciences Oy, Espoo, Finland.
Kalyani DaitaDivision of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA.
Hae-Ki MinDivision of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA.
Andrew JoyceVenebio Group LLC, Richmond, VA.
Faridoddin MirshahiDivision of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA.
Hidekazu TsukamotoUniversity of Southern California, Los Angeles, CA.
Arun J SanyalDivision of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA.
Virginia Commonwealth University · USZora Biosciences (Finland) · FIUniversity of Southern California · USVenebio (United States) · US

Funding

The Southernearch Center for ALPD and CirrhosisP50AA011999 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HIDEKAZU TSUKAMOTO · 1999 to 2026
$45.8M
Effect of Alcohol on Obesity Related Liver DiseaseR01AA020758 · NIAAA · VIRGINIA COMMONWEALTH UNIVERSITY · PI SANYAL, ARUN J · 2011 to 2015
$2.4M
Effect of alcohol on obesity related liver disease: Role of intestinal metabonomeK23AA021179 · NIAAA · VIRGINIA COMMONWEALTH UNIVERSITY · PI PURI, PUNEET · 2012 to 2016
$882k
NIAAA NIH HHS K23 AA021179NIAAA NIH HHS P50 AA011999NIAAA NIH HHS R01 AA020758
6 · The paper itself

Abstract

Alcohol- and obesity-related liver diseases often coexist. The hepatic lipidomics due to alcohol and obesity interaction is unknown. We characterized the hepatic lipidome due to 1) alcohol consumption in lean and obese mice and 2) obesity and alcohol interactions. In the French-Tsukamoto mouse model, intragastric alcohol or isocaloric dextrose were fed with either chow (lean) or high-fat, high-cholesterol diet (obese). Four groups (lean, lean alcohol, obese, and obese alcohol) were studied. MS was performed for hepatic lipidomics, and data were analyzed. Alcohol significantly increased hepatic cholesteryl esters and diacyl-glycerol in lean and obese but was more pronounced in obese. Alcohol produced contrasting changes in hepatic phospholipids with significant enrichment in lean mice versus significant decrease in obese mice, except phosphatidylglycerol, which was increased in both lean and obese alcohol groups. Most lysophospholipids were increased in lean alcohol and obese mice without alcohol use only. Prostaglandin E2; 5-, 8-, and 11-hydroxyeicosatetraenoic acids; and 9- and 13-hydroxyoctadecadienoic acids were considerably increased in obese mice with alcohol use. Alcohol consumption produced distinct changes in lean and obese with profound effects of obesity and alcohol interaction on proinflammatory and oxidative stress-related eicosanoids.

Indexed as

Adipose TissueAnimalsCholesterolDiet, High-FatEicosanoidsEthanolLipid MetabolismLiverLiver DiseasesMaleMiceMice, ObeseObesityOxidative StressTriglyceridesCholesterolEicosanoidsEthanolTriglyceridescyclooxygenasecytochrome P450hydroxyeicosatetraenoic acidslipoxygenaseliverobesityphospholipidsprostaglandins

Identifiers

PMID27020313
PMCPMC4878186
OpenAlexW2330545139

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.